Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool, UK; Department of Internal Medicine, School of Health Sciences, Faculty of Medicine, University of Thessaly, Larissa, Greece.
Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool, UK; Department of Cardiovascular and Metabolic Medicine, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, UK.
Am J Med. 2022 Sep;135(9):e311-e317. doi: 10.1016/j.amjmed.2022.04.030. Epub 2022 May 14.
Embolic stroke of undetermined source (ESUS) represents a heterogeneous subgroup of patients with cryptogenic stroke, in which despite an extensive diagnostic workup the cause of stroke remains uncertain. Identifying covert atrial fibrillation among patients with ESUS remains challenging. The increasing use of cardiac implanted electronic devices (CIED), such as pacemakers, implantable defibrillators, and implantable loop recorders (ILR), has provided important information on the burden of subclinical atrial fibrillation. Accumulating evidence indicate that long-term continuous monitoring, especially in selected patients with ESUS, significantly increases the possibility of atrial fibrillation detection, suggesting it may be a cost-effective tool in secondary stroke prevention. This review summarizes available evidence related to the use of long-term cardiac monitoring and the use of implantable cardiac monitoring devices in patients with ESUS.
不明来源栓塞性脑卒中(ESUS)代表了一类具有隐匿性病因的脑卒中患者的亚组,尽管进行了广泛的诊断性检查,但脑卒中的病因仍然不确定。在 ESUS 患者中识别隐匿性心房颤动仍然具有挑战性。心脏植入式电子设备(CIED)的使用日益增多,如起搏器、植入式除颤器和植入式环路记录器(ILR),为亚临床心房颤动的负担提供了重要信息。越来越多的证据表明,长期连续监测,特别是在 ESUS 患者中进行选择,显著增加了检测到心房颤动的可能性,这表明它可能是二级卒中预防的一种具有成本效益的工具。本综述总结了与长期心脏监测以及在 ESUS 患者中使用植入式心脏监测设备相关的现有证据。